Patient-derived models recapitulate heterogeneity of molecular signatures and drug response in pediatric high-grade glioma

Patient-derived xenografts provide a resource for basic and translational cancer research. Here, the authors generate multiple pediatric high-grade glioma xenografts, use omics technologies to show that they are representative of primary tumours and use them to assess therapeutic response.